How Supplied:
0.05% foam, 50 g and 100 g
Indications and Usage:
Olux is indicated for short-term treatment of the inflammatory and pruritic manifestations of moderate to severe corticosteroid-responsive dermatoses of the scalp, and for short-term treatment of mild to moderate plaque-type psoriasis of non-scalp regions excluding the face and intertriginous areas, in patients 12 years of age. Treatment should be limited to 2 consecutive weeks and patients should not use greater than 50 g per week.
Prescribing Instructions:
Prescribing Information Instructions [PDF]
Side Effects and Contraindications:
Side effects may include burning, dryness, and other reactions at the application site. No localized adverse events were reported in patients with scalp psoriasis. The pooled incidence of local adverse reactions in trials for moderate to severe atopic dermatitis and mild to moderate plaque-type psoriasis with Olux Foam was 1.9% for application site atrophy and 1.6% for application site reaction. Treatment with Olux Foam and Olux-E Foam beyond 2 consecutive weeks is not recommended and the total dosage should not exceed 50 g per week because of the potential for the drug to suppress the hypothalamic-pituitary-adrenal (HPA) axis.
Company:
Stiefel, a GSK Company
888-867-7858
www.stiefel-us.com
www.olux.com
MyList
Drugs
